1
|
Harrison IF, Ismail O, Machhada A, Colgan N, Ohene Y, Nahavandi P, Ahmed Z, Fisher A, Meftah S, Murray TK, Ottersen OP, Nagelhus EA, O’Neill MJ, Wells JA, Lythgoe MF. Impaired glymphatic function and clearance of tau in an Alzheimer's disease model. Brain 2020; 143:2576-2593. [PMID: 32705145 PMCID: PMC7447521 DOI: 10.1093/brain/awaa179] [Citation(s) in RCA: 200] [Impact Index Per Article: 50.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/15/2019] [Revised: 03/28/2020] [Accepted: 04/13/2020] [Indexed: 01/09/2023] Open
Abstract
The glymphatic system, that is aquaporin 4 (AQP4) facilitated exchange of CSF with interstitial fluid (ISF), may provide a clearance pathway for protein species such as amyloid-β and tau, which accumulate in the brain in Alzheimer's disease. Further, tau protein transference via the extracellular space, the compartment that is cleared by the glymphatic pathway, allows for its neuron-to-neuron propagation, and the regional progression of tauopathy in the disorder. The glymphatic system therefore represents an exciting new target for Alzheimer's disease. Here we aim to understand the involvement of glymphatic CSF-ISF exchange in tau pathology. First, we demonstrate impaired CSF-ISF exchange and AQP4 polarization in a mouse model of tauopathy, suggesting that this clearance pathway may have the potential to exacerbate or even induce pathogenic accumulation of tau. Subsequently, we establish the central role of AQP4 in the glymphatic clearance of tau from the brain; showing marked impaired glymphatic CSF-ISF exchange and tau protein clearance using the novel AQP4 inhibitor, TGN-020. As such, we show that this system presents as a novel druggable target for the treatment of Alzheimer's disease, and possibly other neurodegenerative diseases alike.
Collapse
Affiliation(s)
- Ian F Harrison
- UCL Centre for Advanced Biomedical Imaging, Department of Imaging, Division of Medicine, University College London, London, UK
| | - Ozama Ismail
- UCL Centre for Advanced Biomedical Imaging, Department of Imaging, Division of Medicine, University College London, London, UK
| | - Asif Machhada
- UCL Centre for Advanced Biomedical Imaging, Department of Imaging, Division of Medicine, University College London, London, UK
- Department of Neuroscience, Physiology and Pharmacology, University College London, London, UK
| | - Niall Colgan
- UCL Centre for Advanced Biomedical Imaging, Department of Imaging, Division of Medicine, University College London, London, UK
- School of Physics, National University of Ireland Galway, Ireland
| | - Yolanda Ohene
- UCL Centre for Advanced Biomedical Imaging, Department of Imaging, Division of Medicine, University College London, London, UK
| | - Payam Nahavandi
- UCL Centre for Advanced Biomedical Imaging, Department of Imaging, Division of Medicine, University College London, London, UK
| | - Zeshan Ahmed
- Eli Lilly and Company, Erl Wood Manor, Windlesham, Surrey, UK
| | - Alice Fisher
- Eli Lilly and Company, Erl Wood Manor, Windlesham, Surrey, UK
| | - Soraya Meftah
- Eli Lilly and Company, Erl Wood Manor, Windlesham, Surrey, UK
| | - Tracey K Murray
- Eli Lilly and Company, Erl Wood Manor, Windlesham, Surrey, UK
| | - Ole P Ottersen
- Office of the President, Karolinska Institutet, Stockholm, Sweden
| | - Erlend A Nagelhus
- Institute of Basic Medical Sciences, University of Oslo, Oslo, Norway
| | | | - Jack A Wells
- UCL Centre for Advanced Biomedical Imaging, Department of Imaging, Division of Medicine, University College London, London, UK
| | - Mark F Lythgoe
- UCL Centre for Advanced Biomedical Imaging, Department of Imaging, Division of Medicine, University College London, London, UK
| |
Collapse
|
2
|
Harrison IF, Whitaker R, Bertelli PM, O’Callaghan JM, Csincsik L, Bocchetta M, Ma D, Fisher A, Ahmed Z, Murray TK, O’Neill MJ, Rohrer JD, Lythgoe MF, Lengyel I. Optic nerve thinning and neurosensory retinal degeneration in the rTg4510 mouse model of frontotemporal dementia. Acta Neuropathol Commun 2019; 7:4. [PMID: 30616676 PMCID: PMC6322294 DOI: 10.1186/s40478-018-0654-6] [Citation(s) in RCA: 12] [Impact Index Per Article: 2.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/13/2018] [Accepted: 12/20/2018] [Indexed: 01/09/2023] Open
Abstract
Visual impairments, such as difficulties in reading and finding objects, perceiving depth and structure from motion, and impaired stereopsis, have been reported in tauopathy disorders, such as frontotemporal dementia (FTD). These impairments however have been previously attributed to cortical pathologies rather than changes in the neurosensory retina or the optic nerve. Here, we examined tau pathology in the neurosensory retina of the rTg(tauP301L)4510 mouse model of FTD. Optic nerve pathology in mice was also assessed using MRI, and corresponding measurements taken in a cohort of five FTD sufferers and five healthy controls. rTg(tauP301L)4510 mice were imaged (T2-weighted MRI) prior to being terminally anesthetized and eyes and brains removed for immunohistochemical and histological analysis. Central and peripheral retinal labelling of tau and phosphorylated tau (pTau) was quantified and retinal layer thicknesses and cell numbers assessed. MR volumetric changes of specific brain regions and the optic nerve were compared to tau accumulation and cell loss in the visual pathway. In addition, the optic nerves of a cohort of healthy controls and behavioural variant FTD patients, were segmented from T1- and T2-weighted images for volumetric study. Accumulation of tau and pTau were observed in both the central and peripheral retinal ganglion cell (RGC), inner plexiform and inner nuclear layers of the neurosensory retina of rTg(tauP301L)4510 mice. This pathology was associated with reduced nuclear density (− 24.9 ± 3.4%) of the central RGC layer, and a reduced volume (− 19.3 ± 4.6%) and elevated T2 signal (+ 27.1 ± 1.8%) in the optic nerve of the transgenic mice. Significant atrophy of the cortex (containing the visual cortex) was observed but not in other area associated with visual processing, e.g. the lateral geniculate nucleus or superior colliculus. Atrophic changes in optic nerve volume were similarly observed in FTD patients (− 36.6 ± 2.6%). The association between tau-induced changes in the neurosensory retina and reduced optic nerve volume in mice, combined with the observation of optic nerve atrophy in clinical FTD suggests that ophthalmic tau pathology may also exist in the eyes of FTD patients. If tau pathology and neurodegeneration in the retina were to reflect the degree of cortical tau burden, then cost-effective and non-invasive imaging of the neurosensory retina could provide valuable biomarkers in tauopathy. Further work should aim to validate whether these observations are fully translatable to a clinical scenario, which would recommend follow-up retinal and optic nerve examination in FTD.
Collapse
|
3
|
Van de Bittner GC, Riley MM, Cao L, Ehses J, Herrick SP, Ricq EL, Wey HY, O’Neill MJ, Ahmed Z, Murray TK, Smith JE, Wang C, Schroeder FA, Albers MW, Hooker JM. Nasal neuron PET imaging quantifies neuron generation and degeneration. J Clin Invest 2017; 127:681-694. [PMID: 28112682 PMCID: PMC5272198 DOI: 10.1172/jci89162] [Citation(s) in RCA: 9] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/21/2016] [Accepted: 12/01/2016] [Indexed: 01/31/2023] Open
Abstract
Olfactory dysfunction is broadly associated with neurodevelopmental and neurodegenerative diseases and predicts increased mortality rates in healthy individuals. Conventional measurements of olfactory health assess odor processing pathways within the brain and provide a limited understanding of primary odor detection. Quantification of the olfactory sensory neurons (OSNs), which detect odors within the nasal cavity, would provide insight into the etiology of olfactory dysfunction associated with disease and mortality. Notably, OSNs are continually replenished by adult neurogenesis in mammals, including humans, so OSN measurements are primed to provide specialized insights into neurological disease. Here, we have evaluated a PET radiotracer, [11C]GV1-57, that specifically binds mature OSNs and quantifies the mature OSN population in vivo. [11C]GV1-57 monitored native OSN population dynamics in rodents, detecting OSN generation during postnatal development and aging-associated neurodegeneration. [11C]GV1-57 additionally measured rates of neuron regeneration after acute injury and early-stage OSN deficits in a rodent tauopathy model of neurodegenerative disease. Preliminary assessment in nonhuman primates suggested maintained uptake and saturable binding of [18F]GV1-57 in primate nasal epithelium, supporting its translational potential. Future applications for GV1-57 include monitoring additional diseases or conditions associated with olfactory dysregulation, including cognitive decline, as well as monitoring effects of neuroregenerative or neuroprotective therapeutics.
Collapse
Affiliation(s)
| | - Misha M. Riley
- Athinoula A. Martinos Center for Biomedical Imaging, Department of Radiology, and
| | - Luxiang Cao
- Department of Neurology, Massachusetts General Hospital, Harvard Medical School, Charlestown, Massachusetts, USA
| | - Janina Ehses
- Athinoula A. Martinos Center for Biomedical Imaging, Department of Radiology, and
| | - Scott P. Herrick
- Department of Neurology, Massachusetts General Hospital, Harvard Medical School, Charlestown, Massachusetts, USA
| | - Emily L. Ricq
- Athinoula A. Martinos Center for Biomedical Imaging, Department of Radiology, and
- Department of Chemistry and Chemical Biology, Harvard University, Cambridge, Massachusetts, USA
| | - Hsiao-Ying Wey
- Athinoula A. Martinos Center for Biomedical Imaging, Department of Radiology, and
| | - Michael J. O’Neill
- Eli Lilly and Co. Ltd., Lilly Research Centre, Erl Wood Manor, Windlesham, Surrey, United Kingdom
| | - Zeshan Ahmed
- Eli Lilly and Co. Ltd., Lilly Research Centre, Erl Wood Manor, Windlesham, Surrey, United Kingdom
| | - Tracey K. Murray
- Eli Lilly and Co. Ltd., Lilly Research Centre, Erl Wood Manor, Windlesham, Surrey, United Kingdom
| | - Jaclyn E. Smith
- Athinoula A. Martinos Center for Biomedical Imaging, Department of Radiology, and
| | - Changning Wang
- Athinoula A. Martinos Center for Biomedical Imaging, Department of Radiology, and
| | | | - Mark W. Albers
- Department of Neurology, Massachusetts General Hospital, Harvard Medical School, Charlestown, Massachusetts, USA
| | - Jacob M. Hooker
- Athinoula A. Martinos Center for Biomedical Imaging, Department of Radiology, and
| |
Collapse
|
4
|
Kurbatskaya K, Phillips EC, Croft CL, Dentoni G, Hughes MM, Wade MA, Al-Sarraj S, Troakes C, O’Neill MJ, Perez-Nievas BG, Hanger DP, Noble W. Upregulation of calpain activity precedes tau phosphorylation and loss of synaptic proteins in Alzheimer's disease brain. Acta Neuropathol Commun 2016; 4:34. [PMID: 27036949 PMCID: PMC4818436 DOI: 10.1186/s40478-016-0299-2] [Citation(s) in RCA: 81] [Impact Index Per Article: 10.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/08/2016] [Accepted: 03/15/2016] [Indexed: 12/05/2022] Open
Abstract
Alterations in calcium homeostasis are widely reported to contribute to synaptic degeneration and neuronal loss in Alzheimer’s disease. Elevated cytosolic calcium concentrations lead to activation of the calcium-sensitive cysteine protease, calpain, which has a number of substrates known to be abnormally regulated in disease. Analysis of human brain has shown that calpain activity is elevated in AD compared to controls, and that calpain-mediated proteolysis regulates the activity of important disease-associated proteins including the tau kinases cyclin-dependent kinase 5 and glycogen kinase synthase-3. Here, we sought to investigate the likely temporal association between these changes during the development of sporadic AD using Braak staged post-mortem brain. Quantification of protein amounts in these tissues showed increased activity of calpain-1 from Braak stage III onwards in comparison to controls, extending previous findings that calpain-1 is upregulated at end-stage disease, and suggesting that activation of calcium-sensitive signalling pathways are sustained from early stages of disease development. Increases in calpain-1 activity were associated with elevated activity of the endogenous calpain inhibitor, calpastatin, itself a known calpain substrate. Activation of the tau kinases, glycogen-kinase synthase-3 and cyclin-dependent kinase 5 were also found to occur in Braak stage II-III brain, and these preceded global elevations in tau phosphorylation and the loss of post-synaptic markers. In addition, we identified transient increases in total amyloid precursor protein and pre-synaptic markers in Braak stage II-III brain, that were lost by end stage Alzheimer's disease, that may be indicative of endogenous compensatory responses to the initial stages of neurodegeneration. These findings provide insight into the molecular events that underpin the progression of Alzheimer's disease, and further highlight the rationale for investigating novel treatment strategies that are based on preventing abnormal calcium homeostasis or blocking increases in the activity of calpain or important calpain substrates.
Collapse
|
5
|
Scrase TG, O’Neill MJ, Peel AJ, Senior PW, Matthews PD, Shi H, Boss SR, Barker PD. Selective Lability of Ruthenium(II) Arene Amino Acid Complexes. Inorg Chem 2015; 54:3118-24. [DOI: 10.1021/ic502051y] [Citation(s) in RCA: 18] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/17/2023]
Affiliation(s)
- Tom G. Scrase
- University of Cambridge, Chemistry Department, Lensfield Road, Cambridge CB2 1EW, United Kingdom
| | - Michael J. O’Neill
- University of Cambridge, Chemistry Department, Lensfield Road, Cambridge CB2 1EW, United Kingdom
| | - Andrew J. Peel
- University of Cambridge, Chemistry Department, Lensfield Road, Cambridge CB2 1EW, United Kingdom
| | - Paul W. Senior
- University of Cambridge, Chemistry Department, Lensfield Road, Cambridge CB2 1EW, United Kingdom
| | - Peter D. Matthews
- University of Cambridge, Chemistry Department, Lensfield Road, Cambridge CB2 1EW, United Kingdom
| | - Heyao Shi
- University of Cambridge, Chemistry Department, Lensfield Road, Cambridge CB2 1EW, United Kingdom
| | - Sally R. Boss
- University of Cambridge, Chemistry Department, Lensfield Road, Cambridge CB2 1EW, United Kingdom
| | - Paul D. Barker
- University of Cambridge, Chemistry Department, Lensfield Road, Cambridge CB2 1EW, United Kingdom
| |
Collapse
|
6
|
|
7
|
Jue NK, Murphy MB, Kasowitz SD, Qureshi SM, Obergfell CJ, Elsisi S, Foley RJ, O’Neill RJ, O’Neill MJ. Determination of dosage compensation of the mammalian X chromosome by RNA-seq is dependent on analytical approach. BMC Genomics 2013; 14:150. [PMID: 23497106 PMCID: PMC3769146 DOI: 10.1186/1471-2164-14-150] [Citation(s) in RCA: 29] [Impact Index Per Article: 2.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/20/2012] [Accepted: 02/23/2013] [Indexed: 12/22/2022] Open
Abstract
BACKGROUND An enduring question surrounding sex chromosome evolution is whether effective hemizygosity in the heterogametic sex leads inevitably to dosage compensation of sex-linked genes, and whether this compensation has been observed in a variety of organisms. Incongruence in the conclusions reached in some recent reports has been attributed to different high-throughput approaches to transcriptome analysis. However, recent reports each utilizing RNA-seq to gauge X-linked gene expression relative to autosomal gene expression also arrived at diametrically opposed conclusions regarding X chromosome dosage compensation in mammals. RESULTS Here we analyze RNA-seq data from X-monosomic female human and mouse tissues, which are uncomplicated by genes that escape X-inactivation, as well as published RNA-seq data to describe relative X expression (RXE). We find that the determination of RXE is highly dependent upon a variety of computational, statistical and biological assumptions underlying RNA-seq analysis. Parameters implemented in short-read mapping programs, choice of reference genome annotation, expression data distribution, tissue source for RNA and RNA-seq library construction method have profound effects on comparing expression levels across chromosomes. CONCLUSIONS Our analysis shows that the high number of paralogous gene families on the mammalian X chromosome relative to autosomes contributes to the ambiguity in RXE calculations, RNA-seq analysis that takes into account that single- and multi-copy genes are compensated differently supports the conclusion that, in many somatic tissues, the mammalian X is up-regulated compared to the autosomes.
Collapse
Affiliation(s)
- Nathaniel K Jue
- Department of Molecular and Cell Biology, University of Connecticut, 354 Mansfield Rd. U-2131, Storrs, CT 06235, USA
| | - Michael B Murphy
- Department of Molecular and Cell Biology, University of Connecticut, 354 Mansfield Rd. U-2131, Storrs, CT 06235, USA
| | - Seth D Kasowitz
- Department of Molecular and Cell Biology, University of Connecticut, 354 Mansfield Rd. U-2131, Storrs, CT 06235, USA
| | - Sohaib M Qureshi
- Department of Molecular and Cell Biology, University of Connecticut, 354 Mansfield Rd. U-2131, Storrs, CT 06235, USA
| | - Craig J Obergfell
- Department of Molecular and Cell Biology, University of Connecticut, 354 Mansfield Rd. U-2131, Storrs, CT 06235, USA
| | - Sahar Elsisi
- Department of Molecular and Cell Biology, University of Connecticut, 354 Mansfield Rd. U-2131, Storrs, CT 06235, USA
| | - Robert J Foley
- Department of Molecular and Cell Biology, University of Connecticut, 354 Mansfield Rd. U-2131, Storrs, CT 06235, USA
| | - Rachel J O’Neill
- Department of Molecular and Cell Biology, University of Connecticut, 354 Mansfield Rd. U-2131, Storrs, CT 06235, USA
| | - Michael J O’Neill
- Department of Molecular and Cell Biology, University of Connecticut, 354 Mansfield Rd. U-2131, Storrs, CT 06235, USA
| |
Collapse
|
8
|
Qureshi SM, Murphy MB, Kasowitz S, Foley RJ, O’Neill MJ. Identification of a novel imprinting mechanism at the X-linked imprinted locus, X-linked Lymphocyte Regulated 3/4 (Xlr3/4). Epigenetics Chromatin 2013. [PMCID: PMC3600797 DOI: 10.1186/1756-8935-6-s1-p68] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Download PDF] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/20/2022] Open
|
9
|
Weir HJM, Murray TK, Kehoe PG, Love S, Verdin EM, O’Neill MJ, Lane JD, Balthasar N. CNS SIRT3 expression is altered by reactive oxygen species and in Alzheimer's disease. PLoS One 2012; 7:e48225. [PMID: 23139766 PMCID: PMC3491018 DOI: 10.1371/journal.pone.0048225] [Citation(s) in RCA: 90] [Impact Index Per Article: 7.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/12/2012] [Accepted: 09/21/2012] [Indexed: 01/01/2023] Open
Abstract
Progressive mitochondrial dysfunction contributes to neuronal degeneration in age-mediated disease. An essential regulator of mitochondrial function is the deacetylase, sirtuin 3 (SIRT3). Here we investigate a role for CNS Sirt3 in mitochondrial responses to reactive oxygen species (ROS)- and Alzheimer’s disease (AD)-mediated stress. Pharmacological augmentation of mitochondrial ROS increases Sirt3 expression in primary hippocampal culture with SIRT3 over-expression being neuroprotective. Furthermore, Sirt3 expression mirrors spatiotemporal deposition of β-amyloid in an AD mouse model and is also upregulated in AD patient temporal neocortex. Thus, our data suggest a role for SIRT3 in mechanisms sensing and tackling ROS- and AD-mediated mitochondrial stress.
Collapse
Affiliation(s)
| | - Tracey K. Murray
- Neurodegenerative Diseases Drug Hunting Team, Eli Lilly and Co. Ltd., Windlesham, Surrey, United Kingdom
| | - Patrick G. Kehoe
- Dementia Research Group, Institute of Clinical Neurosciences, University of Bristol, Bristol, United Kingdom
| | - Seth Love
- Dementia Research Group, Institute of Clinical Neurosciences, University of Bristol, Bristol, United Kingdom
| | - Eric M. Verdin
- Gladstone Institute of Virology and Immunology, University of California San Francisco, San Francisco, California, United States of America
| | - Michael J. O’Neill
- Neurodegenerative Diseases Drug Hunting Team, Eli Lilly and Co. Ltd., Windlesham, Surrey, United Kingdom
| | - Jon D. Lane
- School of Biochemistry, University of Bristol, Bristol, United Kingdom
- * E-mail: (NB); (JDL)
| | - Nina Balthasar
- School of Physiology and Pharmacology, University of Bristol, Bristol, United Kingdom
- * E-mail: (NB); (JDL)
| |
Collapse
|
10
|
Pennell CE, Henderson JJ, O’Neill MJ, McCleery S, Doherty DA, Dickinson JE. Induction of labour in nulliparous women with an unfavourable cervix: a randomised controlled trial comparing double and single balloon catheters and PGE2 gel. BJOG 2009; 116:1443-52. [DOI: 10.1111/j.1471-0528.2009.02279.x] [Citation(s) in RCA: 141] [Impact Index Per Article: 9.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/28/2022]
|
11
|
Carone DM, Longo MS, Ferreri GC, Hall L, Harris M, Shook N, Bulazel KV, Carone BR, Obergfell C, O’Neill MJ, O’Neill RJ. A new class of retroviral and satellite encoded small RNAs emanates from mammalian centromeres. Chromosoma 2008; 118:113-25. [DOI: 10.1007/s00412-008-0181-5] [Citation(s) in RCA: 116] [Impact Index Per Article: 7.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/22/2008] [Revised: 09/10/2008] [Accepted: 09/11/2008] [Indexed: 01/20/2023]
|